Premium
LC–MS/MS method for determination of seneciphylline and its metabolite, seneciphylline N ‐oxide in rat plasma, and its application to a rat pharmacokinetic study
Author(s) -
Long Feng,
Ji Jie,
Wang Xin,
Wang Lili,
Chen Ting
Publication year - 2021
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.5145
Subject(s) - chemistry , chromatography , protein precipitation , formic acid , metabolite , selected reaction monitoring , pharmacokinetics , electrospray ionization , analyte , bioavailability , sample preparation , detection limit , extraction (chemistry) , high performance liquid chromatography , mass spectrometry , electrospray , tandem mass spectrometry , pharmacology , medicine , biochemistry
A rapid and sensitive ultra‐performance liquid chromatography‐tandem electrospray ionization mass spectrometry (UPLC‐ESI/MS) method was established and validated for simultaneous determination of seneciphylline and its main metabolite in rat plasma. The plasma sample was prepared by simple methanol‐mediated precipitation. Chromatographic separation was achieved within 3 min by gradient elution using acetonitrile and water containing 0.1% formic acid as mobile phase on a Waters ACQUITY BEH C18 column (100 × 2.1 mm, i.d. 1.7 μm). Quantitation was conducted in a positive multiple reaction monitoring mode. The linearity of the method was over the range of 1–1,000 ng/mL, with the lower limit of quantification of 1 ng/mL. The intra‐ and inter‐day precision and accuracy, extraction recovery, and matrix effect of analytes were within the acceptable limit. The analytes were stable during the process of sample collection, preparation, and analysis. The validated method was further applied to a pharmacokinetic study of seneciphylline in rats after oral and intravenous administration. The results revealed that seneciphylline was quickly absorbed into plasma (T max , 0.23–0.32 h) and reached the maximum concentration of 0.82–1.75 μg/mL after oral administration. Both seneciphylline and seneciphylline N ‐oxide were eliminated from plasma quickly. The low system exposure (oral bioavailability, 5.43–10.31%) was related to the extensive metabolism in the liver and microflora.